Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
11.00
+2.43 (28.35%)
Jun 6, 2025, 2:57 PM - Market open
Addex Therapeutics Balance Sheet
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 3.34 | 3.34 | 3.87 | 6.96 | 20.48 | 18.7 | Upgrade
|
| Cash & Short-Term Investments | 3.34 | 3.34 | 3.87 | 6.96 | 20.48 | 18.7 | Upgrade
|
| Cash Growth | -13.55% | -13.55% | -44.44% | -66.04% | 9.57% | -40.72% | Upgrade
|
| Receivables | 0.02 | 0.02 | 0.15 | 0.6 | 0.32 | 0.07 | Upgrade
|
| Prepaid Expenses | 0.17 | 0.17 | 0.22 | 0.27 | 1.12 | 0.5 | Upgrade
|
| Other Current Assets | 0.01 | 0.01 | 0 | 0 | 0.02 | 0.23 | Upgrade
|
| Total Current Assets | 3.54 | 3.54 | 4.23 | 7.83 | 21.94 | 19.49 | Upgrade
|
| Property, Plant & Equipment | 0.04 | 0.04 | 0.35 | 0.4 | 0.54 | 0.63 | Upgrade
|
| Long-Term Investments | 7.09 | 7.09 | - | - | - | - | Upgrade
|
| Other Long-Term Assets | 0.01 | 0.01 | 0.05 | 0.05 | 0.06 | 0.06 | Upgrade
|
| Total Assets | 10.68 | 10.68 | 4.64 | 8.28 | 22.54 | 20.18 | Upgrade
|
| Accounts Payable | 0.25 | 0.25 | 0.98 | 1.28 | 1.79 | 0.98 | Upgrade
|
| Accrued Expenses | 0.54 | 0.54 | 1.4 | 1.72 | 2.06 | 1.51 | Upgrade
|
| Current Portion of Leases | 0.01 | 0.01 | 0.27 | 0.29 | 0.29 | 0.31 | Upgrade
|
| Current Unearned Revenue | - | - | 0.23 | - | - | 0.82 | Upgrade
|
| Total Current Liabilities | 0.8 | 0.8 | 2.89 | 3.28 | 4.13 | 3.62 | Upgrade
|
| Long-Term Leases | 0.03 | 0.03 | 0.07 | 0.09 | 0.19 | 0.26 | Upgrade
|
| Long-Term Unearned Revenue | - | - | 0.09 | - | - | - | Upgrade
|
| Total Liabilities | 1 | 1 | 3.5 | 3.37 | 5.61 | 5.57 | Upgrade
|
| Common Stock | 1.84 | 1.84 | 1.84 | 1.15 | 49.27 | 32.85 | Upgrade
|
| Additional Paid-In Capital | 266.38 | 266.38 | 266.19 | 269.51 | 283.98 | 286.89 | Upgrade
|
| Retained Earnings | -353.36 | -353.36 | -360.42 | -349.86 | -329.06 | -313.71 | Upgrade
|
| Treasury Stock | -0.87 | -0.87 | -0.91 | -6.28 | -11.7 | -6.08 | Upgrade
|
| Comprehensive Income & Other | 95.68 | 95.68 | 94.44 | 90.39 | 24.44 | 14.66 | Upgrade
|
| Shareholders' Equity | 9.68 | 9.68 | 1.15 | 4.91 | 16.93 | 14.61 | Upgrade
|
| Total Liabilities & Equity | 10.68 | 10.68 | 4.64 | 8.28 | 22.54 | 20.18 | Upgrade
|
| Total Debt | 0.04 | 0.04 | 0.34 | 0.37 | 0.48 | 0.57 | Upgrade
|
| Net Cash (Debt) | 3.3 | 3.3 | 3.52 | 6.58 | 20 | 18.13 | Upgrade
|
| Net Cash Growth | -6.29% | -6.29% | -46.52% | -67.08% | 10.34% | -41.50% | Upgrade
|
| Net Cash Per Share | 0.03 | 0.03 | 0.05 | 0.15 | 0.59 | 0.68 | Upgrade
|
| Filing Date Shares Outstanding | 98.34 | 98.34 | 128.26 | 80.88 | 37.9 | 27.12 | Upgrade
|
| Total Common Shares Outstanding | 98.34 | 98.34 | 125.2 | 77.13 | 37.9 | 27.12 | Upgrade
|
| Working Capital | 2.74 | 2.74 | 1.34 | 4.55 | 17.81 | 15.87 | Upgrade
|
| Book Value Per Share | 0.10 | 0.10 | 0.01 | 0.06 | 0.45 | 0.54 | Upgrade
|
| Tangible Book Value | 9.68 | 9.68 | 1.15 | 4.91 | 16.93 | 14.61 | Upgrade
|
| Tangible Book Value Per Share | 0.10 | 0.10 | 0.01 | 0.06 | 0.45 | 0.54 | Upgrade
|
| Machinery | 0.08 | 0.08 | 1.73 | 1.72 | 1.72 | 1.69 | Upgrade
|
Updated Nov 22, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.